Item 5. Other Information
ITEM
5. OTHER INFORMATION
None
ITEM
6. EXHIBIT
Exhibit
Number
Description
(3)
Articles
of Incorporation and Bylaws
3.1
Articles
of Incorporation (incorporated by reference to Exhibit 3.1 to our Annual Report on Form 10-K for the year ended September 30, 2021 filed
on November 24, 2021)
3.2
Bylaws
(incorporated by reference to our Current Report on Form 8-K filed on September 28, 2007)
(31)
Rule
13a-14(a)/15(d)-14(a)Certifications
31.1*
Certification
of Christopher Missling, PhD.
31.2*
Certification
of Sandra Boenisch
(32)
Section
1350 Certifications
32.1**
Certification
of Christopher Missling, PhD and Sandra Boenisch.
(101)
XBRL
101.INS*
XBRL
INSTANCE DOCUMENT
101.SCH*
XBRL
TAXONOMY EXTENSION SCHEMA
101.CAL*
XBRL
TAXONOMY EXTENSION CALCULATION LINKBASE
101.DEF*
XBRL
TAXONOMY EXTENSION DEFINITION LINKBASE
101.LAB*
XBRL
TAXONOMY EXTENSION LABEL LINKBASE
101.PRE*
XBRL
TAXONOMY EXTENSION PRESENTATION LINKBASE
*
Filed herewith.
**
Furnished herewith.
35
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
ANAVEX
LIFE SCIENCES CORP.
/s/Christopher
Missling, PhD
Christopher Missling,
PhD
Chief Executive Officer
(Principal Executive
Officer)
Date: August 9, 2022
/s/Sandra
Boenisch
Sandra Boenisch, CPA,
CGA
Principal Financial
Officer
(Principal Financial
and Accounting Officer)
Date: August 9, 2022
36
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.